β-Carboxylic acid esterified D-Asp-Ala retains a high affinity for the oligopeptide transporter in Caco-2 monolayers

International Journal of Pharmaceutics

Volumn 146, Issue 2, 1997, Pages 205-212

  Taub, Mitchell E ^a   Larsen, Bjarne Due ^b   Steffansen, Bente ^a   Frokjaer, Sven ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KVL   (Denmark)

Author keywords

Carboxylic acid; Caco 2; Dipeptides; Oligopeptide transporter; Uptake

Indexed keywords

AMINO ACID DERIVATIVE; CARRIER PROTEIN; DIPEPTIDE; OLIGOPEPTIDE;

ARTICLE; CELL STRAIN CACO 2; CHEMICAL MODIFICATION; ESTERIFICATION; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; PRIORITY JOURNAL; TRANSPORT AT THE CELLULAR LEVEL;

EID: 0342894662     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04802-8     Document Type: Article

References (18)

1. Bai, J.P.F. and Amidon, G.L., Structural specificity of mucosal-cell transport and metabolism of peptide drugs: Implication for oral peptide drug delivery. Pharm. Res., 9 (1992) 969-978.
2. Daniel, H., Morse, E.L. and Adibi, S.A., Determinants of substrate affinity for the oligopeptide H + symporter in the renal brush border membrane. J. Biol. Chem., 267 (1992) 9565-9573.
3. Dantzig, A.H. and Bergin, L., Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta., 1027 (1990) 211-217.
4. Eddy, E.P., Wood, C., Miller, J., Wilson, G. and Hidalgo, I.J., A comparison of the affinities of dipeptides and antibiotics for the di-/tripeptide transporter in Caco-2 cells. Int. J. Pharm., 115 (1995) 79-86.
5. Fei, Y.J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F.H., Romero, M.F., Singh, S.K., Boron, W.F. and Hediger, M.A., Expression cloning of a mammalian protoncoupled oligopeptide transporter. Nature, 368 (1994) 563-566.
6. Ganapathy, V. and Leibach, F.H., Is intestinal peptide transport energized by a proton gradient? Am. J. Physiol., 249 (1985) G153-G160.
7. Gochoco, C.H., Ryan, F.M., Miller, J., Smith, P.L. and Hidalgo, I.J., Uptake and transepithelial transport of the orally absorbed cephalosporin cephalexin in the human intestinal cell line. Caco-2. Int. J. Pharm., 104 (1994) 187-202.
8. Hidalgo, I.J., Bhatnagar, P., Lee, C.-P., Miller, J., Cucullino, G. and Smith, P.L., Structural requirements for interaction with the oligopeptide transporter in Caco-2 cells. Pharm. Res., 12 (1995) 317-319.
9. Hu, M. and Amidon, G.L., Passive and carrier-mediated intestinal absorption components of Captopril. J. Pharm. Sci., 77 (1988) 1007-1011.
10. Kramer, W., Girbig, F., Gutjagr, U., Kleemann, H., Leipe, I., Urbach, J. and Wagner. A., Interaction of renin inhibitors with the intestinal uptake system for oligopeptide and β-lactam antibiotics. Biochim. Biophys, Acta, 1027 (1990) 25-30.
11. Liang, R., Fei, Y.-J., Prasad, P.D., Ramamoorthy, S., Jan, J., Yang-Feng, T.L., Hediger, M.A., Ganapathy, V. and Leibach, F.H., Human intestinal H +/peptide cotransporter. J. Biol. Chem., 270 (1995) 6456-6463.
12. Matthews, D.M. and S.A. Adibi, Intestinal absorption of peptides. Physiol. Rev., 55 (1976) 537-608.
13. Saito, H. and Inui, K.-I., Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am. J. Physiol., 265 (1993) G289-G294.
14. Smith, P.L., Eddy, E.P., Lee, C.-P. and Wilson, G., Exploitation of the intestinal oligopeptide transporter to enhance drug absorption. Drug Delivery, 1 (1993) 103-111.
15. Swaan, P.W., Stehouwer, M.C., Blok, R.I.C. and Tukker, J.J., Prodrug approach using the intestinal peptide carrier. Pharm. Res., 10 (1993). S-295.
16. Tamura, K., Bhatnagar, P.K., Takata, J.S., Lee, C.-P., Smith, P.L. and Borchardt, R.T., Inhibition of uptake by the oligopeptide transporter does not correlate with transepithelial transport. Pharm. Res., 12 (1995) S-302.
17. + -coupled carriers at both apical and basal membranes. J. Biol. Chem., 268 (1993) 7640-7642.
18. + coupled absorption, Br. J. Pharmacol., 113 (1994) 1050-1056.